Form 4: Glaukos Corp Director Exercises Options and Sells Shares Under 10b5-1 Plan

A Glaukos Corp director, Gilbert H. Kliman, exercised stock options and sold shares under a pre-arranged 10b5-1 trading plan.

Summary

• Director Gilbert H. Kliman exercised 10,000 stock options at a price of $32 per share.
• Concurrently, Mr. Kliman sold 10,000 shares of common stock at a weighted average price of $150.28 per share.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on June 15, 2024.
• Following these transactions, Mr. Kliman beneficially owns 32,336 shares of common stock, which includes 2,611 unvested restricted stock units.

Sentiment

Score: 5

Explanation: The document reflects routine insider trading activity under a pre-arranged plan, which is neither positive nor negative.

Industry Context

This is a routine filing related to insider trading activity, which is common for publicly traded companies. The use of a 10b5-1 plan indicates that the transactions were pre-planned and not based on any material non-public information.

Comparison to Industry Standards

• The use of 10b5-1 trading plans is a common practice among corporate insiders to avoid accusations of insider trading.
• The reported transactions are typical for directors who hold stock options and shares in the company.
• The price range of $150.00 to $150.99 for the share sale is within the expected range for a company of this type.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are part of a pre-planned trading strategy.
• The sale of shares by a director may be perceived as slightly negative by some investors, but the use of a 10b5-1 plan mitigates this concern.

Key Dates

Keywords

Form 4, Glaukos Corp, insider trading, stock options, share sale, Rule 10b5-1, director, equity securities